Let's assume that it is approved on the fast track, despite the fast track requiring some form of efficacy signal from surrogates or interims.
Why would any ethically sound doctor prescribe something that shows no efficacy? Why would an insurance company reimburse for it?
Heart Failure, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.22%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.10 | $2.587M | 2.307M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 160357 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 70396 | 12 |
View Market Depth
| Last trade - 10.55am 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |